Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 2, 2007, Pages 141-147

  Guedes, Paulo M M ^b   Veloso, Vanja M ^b   Caliari, Marcelo V ^a   Carneiro, Cláudia M ^b   Souza, Sheler M ^b   De Lana, Marta ^b   Chiari, Egler ^a   Bahia, Maria T ^b   Galvão, Lúcia M C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Antibodies; Beagle dogs; Cardiac lesions; Chagas disease; Infectivity; Trypanosoma cruzi

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; TRYPANOSOMA CRUZI;

EID: 34047222183     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000200003     Document Type: Article

References (40)

1. Andrade SG, Andrade ZA, Sadigursky M, Maguire JH 1981. Experimental Chagas' disease in dogs. A pathologic and ECG study of the chronic indeterminate phase of the infection. Arch Pathol Lab Med 105: 460-464.
2. Bahia MT, Tafuri WL, Caliari MV, Veloso VM, Carneiro CM, Machado-Coelho GLL, Lana M 2002. Comparison of Trypanosoma cruzi infection in dogs inoculated with blood or metacyclic trypomastigotes of Berenice-62 and Berenice-78 strains via intraperitoneal and conjunctival routes. Rev Soc Bras Med Trop 35: 339-345.
3. Bambirra EA, Tafuri WL, Bogliolo L, Chiari E, Pereira FEL 1984. Trypanosoma cruzi: a follow-up study of tissue reacting immunoglobulins in infected purebred Pinscher dog. Rev Bras Med Trop 17: 205-208.
4. Barr SC, Dennis VA, Klei TR, Norcross NL 1991. Antibody and lymphoblastogenic responses of dogs experimentally infected with Trypanosoma cruzi isolates from North American mammals. Vet Immunol Immunopathol 29: 267-283.
5. Bertelli MS, Brener Z 1980. Infection of tissue culture cells with bloodstream trypomastigotes of Trypanosoma cruzi. J Parasitol 66: 992-997.
6. Bertelli MS, Golgher RR, Brener Z 1977. Intraspecific variation in Trypanosoma cruzi: effect of temperature on the intracellular differentiation in tissue culture. J Parasitol 63: 434-437.
7. Brener Z 1962. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4: 389-396.
8. Brener Z, Chiari E 1963. Variações morfológicas observadas em diferentes amostras de Trypanosoma cruzi. Rev Inst Med Trop São Paulo 5: 220-244.
9. Camargo ME, Amato-Neto V 1974. Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection. Rev Inst Med Trop São Paulo 16: 200-202.
10. Chagas C 1909. Nova tripanozomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolójico de nova entidade mórbida do homem. Mem Inst Oswaldo Cruz 1: 159-218.
11. Cordeiro FD, Martins-Filho AO, Rocha MOC, Adad SJ, Corrêa-Oliveira R, Romanha AJ 2001. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of humam Chagas' disease. Clin Diag Lab Immunol 1: 112-118.
12. Dias JCP 2000. Epidemiological surveillance of Chagas disease. Cad Saúde Pública 16: 43-59.
13. Dutra WO, Rocha MO, Teixeira MM 2005. The clinical immunology of human Chagas disease. Trends Parasitol 21: 581-587.
14. Grauert MR, Houdayer M, Hontebeyrie-Joskowciz M 1993. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease. Clin Exp Immunol 93: 85-92.
15. Guedes PMM 2001. O Cão como Modelo para a Quimioterapia da Doença de Chagas, Universidade Federal de Ouro Preto, Minas Gerais, 106 pp.
16. Guedes PMM, Urbina JA, Lana M, Afonso LC, Veloso VM, Tafuri WL, Machado-Coelho GL, Chiari E, Bahia MT 2004. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob Agents Chemother 48: 4286-4292.
17. Guedes PMM, Veloso VMV, Tafuri WL, Galvão LMC, Carneiro CM, Lana M, Chiari E, Soares KA, Bahia MT 2002. The dog as model for chemotherapy of the Chagas' disease. Acta Trop 84: 9-17.
18. Krettli AU, Brener Z 1976. Protective effects of specific antibodies in Trypanosoma cruzi infections. J Immunol 116: 755-760.
19. Lana M, Chiari CA 1986. Caracterização biológica comparativa das cepas Berenece-78 de Trypanosoma cruzi, isoladas da mesma paciente em diferentes períodos. Mem Inst Oswaldo Cruz 81: 247-253.
20. Lana M, Chiari E, Tafuri WL 1992. Experimental Chagas disease in dogs. Mem Inst Oswaldo Cruz 87: 59-71.
21. Lopes ER, Chapadeiro E, Tafuri WL, Almeida HO, Abrão D 1970. Heart weight and type of death in the patient with chronic Chagas' disease. Rev Inst Med Trop São Paulo 12: 293-297.
22. Macedo AM, Machado CR, Oliveira RP, Pena SD 2004. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz 99: 1-12.
23. Magnani MA, Ferriolli Filho F, de Siqueira AF 1973. Specific immunoglobulins (IgA, IgG, and IgM) in serum of patients with chronic Chagas' disease analyzed by indirect immunofluorescence reactions. Rev Inst Med Trop São Paulo 15: 72-75.
24. Maltos KL, Menezes GB, Caliari MV, Rocha OA, Santos JM, Alves DL, Duarte ID, Francischi JN 2004. Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp. Arch Oral Biol 49: 443-450.
25. Marques de Araújo SM, Chiari E 1988. Biological characterization of clones of the Y, CL and MR strains of Trypanosoma cruzi in inbred C3H mice. Mem Inst Oswaldo Cruz 83: 175-181.
26. Medrano-Mercado N, Luz MR, Torrico F, Tapia G, Van Leuven F, Araujo-Jorge TC 1996. Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia. Am J Trop Med Hyg 54: 154-161.
27. Morgan J, Dias JCP, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR 1996. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 55: 355-359.
28. Ouaissi MA, Taibi A, Loyens M, Martin U, Afchain D, Maidana C, Caudioti C, Cornette J, Martelleur A, Velge P 1991. Trypanosoma cruzi: a carbohydrate epitope defined by a monoclonal antibody as a possible marker of the acute phase of human Chagas' disease. Am J Trop Med Hyg 45: 214-225.
29. Penin P, Gamallo C, Gonzalez M, De Diego JA 1997. Morphological and morphometric variability of three clones of Trypanosoma cruzi and the strain of origin (Bolivia). Medicina (B Aires) 57: 571-580.
30. Salgado JA, Garcez PM, Oliveira CA, Galizzi J 1962. Revisão clínica atual do primeiro caso humano descrito da doença de Chagas. Rev Inst Med Trop São Paulo 4: 330-337.
31. Schmatz DM, Boltz RC, Murray PK 1983. Trypanosoma cruzi: separation of broad and slender trypomastigotes using a continuous hypaque gradient. Parasitology 87: 219-227.
32. Schmidt DR, Hogh B, Andersen O, Hansen SH, Dalhoff K, Petersen E 2006. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine. Eur J Pediatr 165: 19-25.
33. Scott MT, Goss-Sampson M 1984. Restricted IgG isotype profiles in T. cruzi infected mice and Chagas' disease patients. Clin Exp Immunol 58: 372-379.
34. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C 2006. Cord blood screening for congenital toxoplasmosis in Northwestern Switzerland, 1982-1999. Pediatr Infect Dis J 25: 123-128.
35. Silva LHP, Nussenzweig V 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin Biol 20: 191-203.
36. Snedecor GW, Cochran WG 1989. Statistical Methods, 8th ed., Yowa State University press, Ames, Yowa, 262 pp.
37. Tafuri WL 1970. Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. Am J Trop Med Hyg 19: 405-417.
38. Veloso VM, Romanha AJ, Lana M, Murta SM, Carneiro CM, Alves CF, Borges EC, Tafuri WL, Machado-Coelho GL, Chiari E, Bahia MT 2005. Influence of the long-term Trypanosoma cruzi infection in vertebrate host on the genetic and biological diversity of the parasite. Parasitol Res 96: 382-389.
39. Voller A, Bidwell DE, Bartlett A 1976. Enzyme immunoassays in diagnostic medicine. Theory and pratice. Bull WHO 53: 55-65.
40. WHO-World Health Organization 2005. Tropical Disease Research: progress 2003-2004. Special Programme for Research & Training in Tropical Diseases. Programme Report 17, Geneva.